EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Preclinical evaluation of high-resolution CT, 18F-FDG, and 18F-NaF PET imaging for longitudinal monitoring of atherosclerosis

Mikayla Tamboline, Jeffrey Collins, William Jackson, Wenduo Gu, Matthew Worssam, Paul Cheng, John David, Richard Taschereau, Arion F Chatziioannou, Simon Jackson, Shili Xu iD, Oluwatayo F Ikotun

European Journal of Nuclear Medicine and Molecular Imaging · 2025-09 · 52 (11) · 4256-4267

DOI: 10.1007/s00259-025-07276-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 28.04.2025. Verfasst von Mikayla Tamboline und 11 weiteren Autor:innen. Beteiligte Einrichtung: Crump Institute for Molecular Imaging, University of California, Los Angeles, Los Angeles, CA, 90025, USA. Hauptthemen laut MEDLINE: Fluorodeoxyglucose F18, Sodium Fluoride, Atherosclerosis, Positron Emission Tomography Computed Tomography. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NCI NIH HHS, UCLA Clinical and Translational Science Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rationale

Detection of atherosclerosis is essential to the management and prevention of life-threatening cardiovascular events. Although non-invasive imaging modalities, such as 18 F-sodium fluoride ( 18 F-NaF), 18 F-fluorodeoxyglucose ( 18 F-FDG) PET, and CT, visualize distinct hallmarks of atherosclerosis, there has yet to be a singular multi-cohort interrogation of their strengths and limitations. Thus, we focused on identifying the optimal approach for visualizing atherosclerosis at different stages of disease progression.

Methods

In this study, 6-week-old, male, ApoE deficient mice ( Apoe −/− ) were placed on a high cholesterol diet for 12–20 weeks to induce calcific atherosclerotic disease. Age-matched, male, wildtype (WT) C57BL/6 mice fed with regular chow served as the control group. Mice were imaged at 12, 15, 18, and 20 weeks after starting their respective diets. To follow the progression of calcified atherosclerotic lesions, at each time point, in vivo , 18 F-NaF microPET/CT images were acquired 1 h and 3 h post tracer i.v. injection. In a separate cohort, in vivo 18 F-FDG PET/CT images were acquired at 3 and 5 h post tracer i.v. injection to follow inflammation as a result of progressive atherosclerotic lesion formation. High-resolution microCT images were acquired for all mice to visualize aorta calcification. After each imaging session, a subset ( n = 3) was euthanized from each group and histological analysis of the aorta was performed to confirm disease progression.

Results

In this comparative study, within the same cohort, 18 F-NaF PET detected atherosclerotic calcification earlier than microCT. At both 1 and 3 h post-injection (p.i.), calcified lesions were clearly detected by 18 F-NaF with a six-fold higher signal in Apoe -/- compared to WT mice. Interestingly, 18 F-NaF signal peaked at week 18, whereas aortic CT signal progressively increased with a 13-, 16-, and 29-fold at 15, 18, and 20 weeks, respectively. 18 F-FDG arortic accumulation at weeks 12 and 15, were significantly greater in Apoe −/− mice than WT control when images were acquired at 5 h but not at 3 h p.i.. In contrast to histological analysis, at ≥ 16 weeks where inflammation is significantly elevated, 18 F-FDG was equivalent in Apoe −/− and WT control mice and significantly reduced with disease progression.

Conclusions

Our results show that 18 F-NaF PET and 18 F-FDG PET are sensitive imaging modalities for the early detection of atherosclerotic lesions. However, both 18 F-NaF PET and high-resolution microCT prove to be effective methods for monitoring late-stage and progressive disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fluorodeoxyglucose F18Sodium FluorideAtherosclerosisPositron Emission Tomography Computed TomographyTomography, X-Ray ComputedAnimalsMiceMaleMice, Inbred C57BLDisease ProgressionFluorine RadioisotopesRadiopharmaceuticalsLongitudinal Studies

Stichwörter der Autor:innen

18F-FDG18F-NaFAortaAtherosclerosisCTCalcificationDiagnosisPET

Substanzen

Fluorodeoxyglucose F18Sodium FluorideFluorine RadioisotopesRadiopharmaceuticals

Autor:innen und Institutionen

  • Crump Institute for Molecular Imaging, University of California, Los Angeles, Los Angeles, CA, 90025, USA.
  • Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA, 90025, USA.
  • Department of Medicine, Division of Cardiovascular Medicine, Stanford University, Stanford, CA, 94305, USA.
  • Stanford Cardiovascular Institute, Stanford University, Stanford, CA, 94305, USA.
  • Cardiovascular, Amgen Inc., Thousand Oaks, CA, 91320, USA.
  • Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, 90025, USA.

ORCID-Profile: Shili Xu

Förderung

  • NIH HHS
  • NCI NIH HHS
  • UCLA Clinical and Translational Science Institute
  • NCATS NIH HHS
  • NIH S10 Shared Instrumentation for Animal Research
  • NIH

Zitieren

APA

Tamboline, M., Collins, J., Jackson, W., Gu, W., Worssam, M., Cheng, P., David, J., Taschereau, R., Chatziioannou, A. F., Jackson, S., Xu, S., & Ikotun, O. F. (2025). Preclinical evaluation of high-resolution CT, 18F-FDG, and 18F-NaF PET imaging for longitudinal monitoring of atherosclerosis. European Journal of Nuclear Medicine and Molecular Imaging, 52(11), 4256-4267. https://doi.org/10.1007/s00259-025-07276-1

Vancouver

Tamboline M, Collins J, Jackson W, Gu W, Worssam M, Cheng P, et al. Preclinical evaluation of high-resolution CT, 18F-FDG, and 18F-NaF PET imaging for longitudinal monitoring of atherosclerosis. European Journal of Nuclear Medicine and Molecular Imaging. 2025;52(11):4256-4267. doi:10.1007/s00259-025-07276-1

BibTeX
@article{Tamboline2025,
  author = {Tamboline, Mikayla and Collins, Jeffrey and Jackson, William and Gu, Wenduo and Worssam, Matthew and Cheng, Paul and David, John and Taschereau, Richard and Chatziioannou, Arion F and Jackson, Simon and Xu, Shili and Ikotun, Oluwatayo F},
  title = {Preclinical evaluation of high-resolution CT, 18F-FDG, and 18F-NaF PET imaging for longitudinal monitoring of atherosclerosis},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2025},
  volume = {52},
  number = {11},
  pages = {4256--4267},
  doi = {10.1007/s00259-025-07276-1}
}
Kostenlos starten →